15% Tariff Pending on Some Travel Vaccines

The European Union (EU) and the United States government have announced the details of a Framework on an Agreement on Reciprocal, Fair, and Balanced Trade (Framework Agreement), which includes pharmaceutical products such as vaccines.

The mutual agreement includes 15% tariffs on EU exports to the United States. 

The August 21, 2025, statement confirmed that the U.S. and the EU, in line with their relevant internal procedures, will promptly document the Framework Agreement, which should reveal which EU-produced vaccines are subject to this tariff, which may impact the cost to consumers in the U.S. 

This pending vaccine list may include high-demand travel vaccines for chikungunya, cholera, and Japanese Encephalitis.